CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity.
Rossi F, Bellini G, Tortora C, Bernardo MEster, Luongo L, Conforti A, Starc N, Manzo I, Nobili B, Locatelli F, et al. CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity. Pharmacol Res. 2015.